Open AccessPemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer
Author(s) -
Joan H. Schiller,
Joachim von Pawel,
Philipp Schütt,
Rafat Ansari,
Michael Thomas,
Mansoor N. Saleh,
Robert D. McCroskey,
Wolfgang Pfeifer,
Thomas Marsland,
Goetz Kloecker,
Martin Sebastian,
Robert Pirker,
Raffael Kurek,
Claire Beadman,
Mark A. Socinski
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/zpq6-ck16
Subject(s) - pemetrexed , medicine , stage (stratigraphy) , second line treatment , oncology , lung cancer , second line , first line , chemotherapy , biology , cisplatin , paleontology